Fresh Tracks Therapeutics...

NASDAQ: FRTX · Real-Time Price · USD
0.94
0.00 (0.00%)
At close: Feb 28, 2025, 12:19 PM

Fresh Tracks Therapeutics Revenue

Fresh Tracks Therapeutics reported an annual revenue of $8.01M, reflecting a 15.31% growth. For the quarter ending December 31, 2023, Fresh Tracks Therapeutics generated $0 in revenue.
Revenue (ttm)
8.01M
Revenue Growth
15.31%
Price / Sales Ratio
0.65
Revenue / Employee
2M
Employees
4
Market Cap
5.59M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Dec 31, 2023 8.01M +15.31%
Dec 31, 2022 6.94M +1618.56%
Dec 31, 2021 404K -77.83%
Dec 31, 2020 1.82M -76.99%
Dec 31, 2019 7.92M +388.10%
Dec 31, 2018 1.62M -88.26%
Dec 31, 2017 13.82M -4.90%
Dec 31, 2016 14.53M -30.64%
Dec 31, 2015 20.95M +37.67%
Dec 31, 2014 15.22M +97.16%
Dec 31, 2013 7.72M -55.94%
Dec 31, 2012 17.52M -41.64%
Dec 31, 2011 30.02M +244.60%
Dec 31, 2010 8.71M -31.33%
Dec 31, 2009 12.69M +59.45%
Dec 31, 2008 7.96M +44.34%
Dec 31, 2007 5.51M -62.61%
Dec 31, 2006 14.74M +22.80%
Dec 31, 2005 12M -17.48%
Dec 31, 2004 14.54M +80.05%
Dec 31, 2003 8.08M +15.29%
Dec 31, 2002 7.01M -38.35%
Dec 31, 2001 11.37M +49.16%
Dec 31, 2000 7.62M -28.78%
Dec 31, 1999 10.7M +81.36%
Dec 31, 1998 5.9M -24.36%
Dec 31, 1997 7.8M +16.42%
Dec 31, 1996 6.7M +6.35%
Dec 31, 1995 6.3M +14.55%
Dec 31, 1994 5.5M -8.33%
Dec 31, 1993 6M +66.67%
Dec 31, 1992 3.6M +50.00%
Dec 31, 1991 2.4M +33.33%
Dec 31, 1990 1.8M n/a
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.